TY - JOUR A1 - Tischer, Christina A1 - Stupp, Carolin A1 - Janson, Patrick A1 - Willeke, Kristina A1 - Hung, Chu-Wei A1 - Flöter, Jessica A1 - Kirchner, Anna A1 - Zink, Katharina A1 - Eder, Lisa A1 - Hackl, Christina A1 - Mühle, Ursula A1 - Weidmann, Manfred A1 - Nennstiel, Uta A1 - Kuhn, Joseph A1 - Weidner, Christian A1 - Liebl, Bernhard A1 - Wildner, Manfred A1 - Keil, Thomas T1 - Evaluation of screening tests in Bavarian healthcare facilities during the second wave of the SARS-CoV-2 pandemic JF - International Journal of Environmental Research and Public Health N2 - Due to the lack of data on asymptomatic SARS-CoV-2-positive persons in healthcare institutions, they represent an inestimable risk. Therefore, the aim of the current study was to evaluate the first 1,000,000 reported screening tests of asymptomatic staff, patients, residents, and visitors in hospitals and long-term care (LTC) facilities in the State of Bavaria over a period of seven months. Data were used from the online database BayCoRei (Bavarian Corona Screening Tests), established in July 2020. Descriptive analyses were performed, describing the temporal pattern of persons that tested positive for SARS-CoV-2 by real-time polymerase chain reaction (RT-PCR) or antigen tests, stratified by facility. Until 15 March 2021, this database had collected 1,038,146 test results of asymptomatic subjects in healthcare facilities (382,240 by RT-PCR, and 655,906 by antigen tests). Of the RT-PCR tests, 2.2% (n = 8380) were positive: 3.0% in LTC facilities, 2.2% in hospitals, and 1.2% in rehabilitation institutions. Of the antigen tests, 0.4% (n = 2327) were positive: 0.5% in LTC facilities, and 0.3% in both hospitals and rehabilitation institutions, respectively. In LTC facilities and hospitals, infection surveillance using RT-PCR tests, or the less expensive but less sensitive, faster antigen tests, could facilitate the long-term management of the healthcare workforce, patients, and residents. KW - SARS-CoV-2 KW - asymptomatic screening KW - RT-PCR KW - antigen testing KW - infection surveillance Y1 - 2021 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-242637 SN - 1660-4601 VL - 18 IS - 14 ER -